Biochemistry
7 systems · 28 topic hubs · 205 MCQs · 37 PYQs
Subject overview
Biochemistry
Biochemistry is the molecular grammar of medicine. In the NEET PG and INI-CET universe it is a pre-clinical subject that punches far above its formal teaching hours, because almost every clinical question about a "single enzyme defect," a "deficiency disease," a "tumour marker," or a "newborn screening abnormality" ultimately traces back to a biochemical pathway. A candidate who treats Biochemistry as rote pathway-drawing will struggle; a candidate who treats it as a defect-to-symptom mapping exercise will score consistently. This mother page is built around the seven official groups for this subject — Carbohydrates, Lipids, Proteins & Amino acids, Enzymes, Vitamins, Molecular Biology, and Metabolism — and treats each as a question-generating engine.
How Biochemistry Is Tested in NEET PG / INI-CET
Weightage and exam footprint
Biochemistry is a moderate-weight, high-yield-per-page subject. In the 200-question NEET PG paper, the pre-clinical trio (Anatomy, Physiology, Biochemistry) collectively contribute roughly 25–30 questions, of which Biochemistry reliably delivers 7–10 questions. In INI-CET (AIIMS/PGI pattern, 200 questions), Biochemistry is more heavily and more cleverly tested — expect 10–14 questions, often integrated with Pathology, Genetics and Medicine, and frequently in the assertion-reason or multi-statement format that AIIMS favours.
The reason the subject "feels small but tests big": Biochemistry questions migrate into other subjects. A "tumour lysis syndrome — which crystal" question lives in Medicine but is answered with purine metabolism. A "boy with self-mutilation, hyperuricaemia" question is Paediatrics on the surface and Lesch-Nyhan biochemistry underneath. So the true Biochemistry footprint is much larger than the labelled count.
Recurring question styles
| Style | What it looks like | How to crack it |
|---|---|---|
| Enzyme-defect → disease | "Defect in fructose-1-phosphate aldolase causes…" | Memorise the enzyme-disease-accumulating substrate triad |
| Rate-limiting / regulatory enzyme | "Rate-limiting enzyme of cholesterol synthesis?" | Maintain a single consolidated RLS table |
| Vitamin deficiency clinical vignette | "Alcoholic with confusion, ophthalmoplegia, ataxia" | Map deficiency → enzyme cofactor → syndrome |
| Cofactor / coenzyme identity | "Active form of vitamin B6?" | Know active forms and the reactions they serve |
| Newborn screening / inborn error | "Positive Guthrie test / mousy odour urine" | Link screening test → metabolite → enzyme |
| Molecular biology technique | "Technique to detect a specific protein?" | Probe-target table (Southern/Northern/Western) |
| Lab value / cut-off | "Diagnostic HbA1c for diabetes?" | Keep a numbers sheet (criteria/values) |
| Image-based | Ramachandran plot, double-reciprocal plot, blotting gel | Recognise the classic graphs cold |
INI-CET adds "all are true except," "which of the following is correctly matched," and assertion-reasoning, which punish half-knowledge. The defence is precision on associations, not breadth.
Group 1: Carbohydrates
High-yield core
Carbohydrate chemistry questions cluster around isomerism, glycosaminoglycans (GAGs), and the bedside chemistry of glucose.
- Isomers and key terms: epimers (glucose vs galactose differ at C4; glucose vs mannose at C2), anomers (α vs β at the anomeric carbon), enantiomers (D vs L mirror images). Reducing sugars (glucose, galactose, fructose, lactose, maltose) reduce Benedict's/Fehling's; sucrose is the classic non-reducing sugar because both anomeric carbons are locked in the glycosidic bond.
- GAGs: repeating disaccharide units of amino sugar + uronic acid. Heparin is the most acidic GAG and the only intracellular one (mast cells). Hyaluronic acid is the only GAG that is not sulphated and not protein-bound. Keratan sulphate is the only GAG lacking uronic acid.
- Glycoproteins vs proteoglycans vs mucopolysaccharides distinctions are frequently asked.
Classic associations and disorders
| Disorder | Enzyme defect | Accumulating substance | Clinical clue |
|---|---|---|---|
| Hurler syndrome (MPS I) | α-L-iduronidase | Dermatan + heparan sulphate | Coarse facies, corneal clouding, intellectual disability |
| Hunter syndrome (MPS II) | Iduronate-2-sulphatase | Dermatan + heparan sulphate | X-linked, NO corneal clouding |
| Von Gierke (GSD I) | Glucose-6-phosphatase | Glycogen in liver/kidney | Severe fasting hypoglycaemia, hepatomegaly, lactic acidosis, hyperuricaemia |
| Pompe (GSD II) | Lysosomal α-1,4-glucosidase (acid maltase) | Glycogen in lysosomes | Cardiomegaly, hypotonia, early death |
| McArdle (GSD V) | Muscle phosphorylase | Glycogen in muscle | Exercise intolerance, second-wind phenomenon, no rise in lactate |
| Galactosaemia (classic) | Galactose-1-phosphate uridyltransferase | Galactose-1-phosphate | Cataract, jaundice, E. coli sepsis, hepatomegaly |
| Hereditary fructose intolerance | Aldolase B | Fructose-1-phosphate | Hypoglycaemia after fruit/sucrose; aversion to sweets |
| Essential fructosuria | Fructokinase | Fructose | Benign, asymptomatic |
Traps students fall for
- Hunter has no corneal clouding (X-linked) while Hurler does — the single most repeated MPS distractor.
- McArdle disease shows a flat lactate curve on the ischaemic forearm exercise test, whereas mitochondrial myopathies behave differently — examiners love this graph.
- Confusing galactokinase deficiency (isolated cataracts, benign) with classic galactosaemia (multisystem, fatal if untreated).
- Essential fructosuria and essential pentosuria are benign — easy marks if you do not panic at the long name.
Group 2: Lipids
High-yield core
Lipid questions revolve around lipoprotein metabolism, dyslipidaemias, fatty acid oxidation, and sphingolipidoses.
- Apolipoproteins are perennial favourites: ApoB-48 = chylomicrons (exogenous); ApoB-100 = VLDL/IDL/LDL (endogenous); ApoA-1 = HDL, activates LCAT; ApoC-II = activates lipoprotein lipase (LPL); ApoE = remnant uptake by liver.
- Lipoprotein lipase clears triglycerides from chylomicrons/VLDL; hepatic lipase and LCAT (cholesterol esterification in plasma) and CETP round out the transport circuit.
- Rate-limiting enzyme of cholesterol synthesis = HMG-CoA reductase (target of statins). Fatty acid synthesis RLS = acetyl-CoA carboxylase (needs biotin + citrate). Ketogenesis RLS = HMG-CoA synthase (mitochondrial).
- Carnitine shuttle (CPT-1) transports long-chain fatty acids into mitochondria for β-oxidation; CPT-1 is rate-limiting and inhibited by malonyl-CoA — the elegant switch that prevents simultaneous synthesis and oxidation.
Familial dyslipidaemias (Fredrickson)
| Type | Defect | Elevated particle | Clue |
|---|---|---|---|
| I | LPL or ApoC-II deficiency | Chylomicrons | Eruptive xanthomas, pancreatitis, no premature CAD |
| IIa | LDL receptor (familial hypercholesterolaemia) | LDL | Tendon xanthomas, corneal arcus, early CAD |
| IIb | ↑ApoB | LDL + VLDL | Combined hyperlipidaemia |
| III | ApoE2/E2 defect | IDL (remnants) | Palmar (tuberoeruptive) xanthomas |
| IV | ↑VLDL production | VLDL | Associated with diabetes/obesity |
| V | LPL + VLDL | Chylomicrons + VLDL | Pancreatitis |
Sphingolipidoses
| Disease | Enzyme | Accumulates | Hallmark |
|---|---|---|---|
| Tay-Sachs | Hexosaminidase A | GM2 ganglioside | Cherry-red spot, no hepatosplenomegaly |
| Niemann-Pick | Sphingomyelinase | Sphingomyelin | Cherry-red spot + hepatosplenomegaly |
| Gaucher (most common) | Glucocerebrosidase | Glucocerebroside | Crumpled-tissue-paper cells, hepatosplenomegaly, bone pain |
| Fabry (X-linked) | α-Galactosidase A | Ceramide trihexoside | Angiokeratoma, renal failure, neuropathic pain |
| Krabbe | Galactocerebrosidase | Galactocerebroside | Globoid cells, optic atrophy |
| Metachromatic leukodystrophy | Arylsulphatase A | Sulphatide | Demyelination, ataxia |
Traps
- Tay-Sachs vs Niemann-Pick: both have a cherry-red spot; hepatosplenomegaly is present in Niemann-Pick and absent in Tay-Sachs. This single distinguisher is asked relentlessly.
- Fabry and Hunter are the two X-linked lysosomal disorders — examiners pair them as "which is X-linked."
- ApoC-II vs ApoA-1 activation: ApoC-II → LPL, ApoA-1 → LCAT. Swapping these is the standard distractor.
- Refsum disease (phytanic acid, defective α-oxidation) presents with retinitis pigmentosa, ataxia, peripheral neuropathy — treat by dietary chlorophyll/phytanic acid restriction.
Group 3: Proteins & Amino Acids
High-yield core
This group covers protein structure, the Ramachandran plot, collagen biochemistry, and the inborn errors of amino acid metabolism (IEM) — the densest IEM territory in the paper.
- Protein structure levels: primary (peptide bonds), secondary (α-helix/β-sheet, H-bonds), tertiary (3D, multiple bonds incl. disulphide), quaternary (subunits). The Ramachandran plot (φ vs ψ) shows allowed conformations; glycine has the most flexibility, proline the least.
- Collagen: triple helix of Gly-X-Y repeats (X often proline, Y often hydroxyproline). Hydroxylation of proline/lysine needs vitamin C; glycosylation, then secretion, then cleavage of propeptides, then cross-linking by lysyl oxidase (copper-dependent). Defects: osteogenesis imperfecta (type I collagen), Ehlers-Danlos (multiple types), Menkes (copper/lysyl oxidase), scurvy (vitamin C).
Inborn errors of amino acid metabolism
| Disorder | Enzyme defect | Accumulates | Clinical hallmark |
|---|---|---|---|
| Phenylketonuria (PKU) | Phenylalanine hydroxylase (or BH4) | Phenylalanine | Mousy/musty odour, fair skin, intellectual disability; treat low-Phe diet |
| Alkaptonuria | Homogentisate oxidase | Homogentisic acid | Urine darkens on standing, ochronosis, arthritis |
| Maple syrup urine disease | Branched-chain α-ketoacid dehydrogenase | Leucine/isoleucine/valine | Maple syrup urine odour, needs thiamine |
| Homocystinuria | Cystathionine β-synthase | Homocysteine | Marfanoid, downward lens dislocation, thrombosis |
| Cystinuria | Renal dibasic AA transporter (COLA) | Cystine | Hexagonal crystals, recurrent renal stones |
| Tyrosinaemia type I | Fumarylacetoacetate hydrolase | Succinylacetone | Liver failure, cabbage-like odour |
| Histidinemia / Hartnup | — | — | Hartnup → pellagra-like, neutral aminoaciduria |
One-carbon / sulphur metabolism
- Homocysteine sits at a crossroads: remethylation to methionine needs B12 + folate (methionine synthase); transsulphuration to cysteine needs B6 (cystathionine β-synthase). Hence B12, B6 and folate deficiencies all raise homocysteine — a recurrent integrated question.
- SAM (S-adenosylmethionine) is the universal methyl donor.
Traps
- Lens dislocation direction: down and in = homocystinuria; up and out = Marfan. A perennial two-mark trap.
- Alkaptonuria urine darkens on standing/alkalinisation — distinguish from porphyria (darkens on light exposure).
- PKU classic odour is mousy/musty; MSUD is maple syrup/burnt sugar; isovaleric acidaemia is sweaty feet; tyrosinaemia is boiled cabbage. The "odour-disease" match is a guaranteed question.
- Treating PKU mothers in pregnancy (maternal PKU) to prevent fetal microcephaly is a modern twist.
Group 4: Enzymes
High-yield core
Enzymology questions are graph-heavy and concept-heavy — the most reliably scoreable group for a prepared candidate.
- Michaelis-Menten kinetics: Km is the substrate concentration at half Vmax. Low Km = high affinity. The Lineweaver-Burk (double-reciprocal) plot linearises the curve; recognising it on sight is essential.
- Inhibition patterns (the single most asked enzyme topic):
| Inhibition | Km | Vmax | Lineweaver-Burk |
|---|---|---|---|
| Competitive | ↑ | unchanged | Same y-intercept, different x-intercept |
| Non-competitive | unchanged | ↓ | Same x-intercept, different y-intercept |
| Uncompetitive | ↓ | ↓ | Parallel lines |
- Allosteric enzymes show sigmoid kinetics (e.g., phosphofructokinase-1, aspartate transcarbamoylase). PFK-1 is the rate-limiting/committed step of glycolysis, activated by AMP and fructose-2,6-bisphosphate, inhibited by ATP and citrate.
- Coenzyme-vitamin pairs bridge this group with Vitamins (see table below).
Classic clinical enzyme associations (competitive inhibition examples)
- Methanol/ethylene glycol poisoning → treat with fomepizole or ethanol (competitive inhibition of alcohol dehydrogenase).
- Statins inhibit HMG-CoA reductase (competitive).
- Allopurinol inhibits xanthine oxidase.
- Physostigmine/neostigmine inhibit acetylcholinesterase.
Diagnostic enzymes (overlaps with Pathology/Medicine)
| Enzyme | Use |
|---|---|
| Troponin I/T, CK-MB | Myocardial infarction |
| ALT > AST | Viral hepatitis |
| AST > ALT (ratio >2) | Alcoholic liver disease |
| ALP, GGT | Cholestasis (GGT confirms hepatic origin of raised ALP) |
| Amylase, lipase | Acute pancreatitis (lipase more specific) |
| ACE | Sarcoidosis |
Traps
- Competitive inhibition: Vmax unchanged, Km increased. Students reverse this constantly.
- Isoenzyme LDH-1 > LDH-2 flip in MI is an older but still-tested concept.
- Macro-enzymes and the difference between zymogen activation (irreversible, e.g., trypsinogen) and allosteric/covalent regulation (reversible).
Group 5: Vitamins
High-yield core
Vitamins are the single highest-yield Biochemistry group because every deficiency is a ready-made clinical vignette. Know the active form, the coenzyme function, the deficiency syndrome, and the toxicity.
| Vitamin | Active form / coenzyme | Key reaction | Deficiency |
|---|---|---|---|
| B1 (thiamine) | TPP | Pyruvate/α-KG dehydrogenase, transketolase | Wet/dry beriberi, Wernicke-Korsakoff |
| B2 (riboflavin) | FAD/FMN | Redox flavoproteins | Angular stomatitis, cheilosis |
| B3 (niacin) | NAD/NADP | Dehydrogenases | Pellagra: dermatitis, diarrhoea, dementia |
| B5 (pantothenate) | Coenzyme A | Acyl transfer | Burning feet syndrome |
| B6 (pyridoxine) | PLP (pyridoxal phosphate) | Transamination, decarboxylation, ALA synthase | Sideroblastic anaemia, neuropathy, seizures |
| B7 (biotin) | Biotin | Carboxylases | Dermatitis, alopecia (raw egg white → avidin) |
| B9 (folate) | THF | One-carbon transfer | Megaloblastic anaemia, NTDs |
| B12 (cobalamin) | Methyl-/adenosyl-cobalamin | Methionine synthase, methylmalonyl-CoA mutase | Megaloblastic anaemia + subacute combined degeneration |
| C (ascorbate) | — | Collagen hydroxylation, antioxidant | Scurvy, corkscrew hairs, bleeding gums |
| A (retinol) | Retinal/retinoic acid | Vision, epithelium | Night blindness, Bitot spots, xerophthalmia |
| D | 1,25-(OH)₂-cholecalciferol (calcitriol) | Ca/PO₄ homeostasis | Rickets, osteomalacia |
| E (tocopherol) | — | Antioxidant | Haemolysis, neuropathy |
| K | — | γ-carboxylation of clotting factors II, VII, IX, X | Bleeding, ↑PT |
Classic associations and criteria
- Wernicke encephalopathy triad: confusion + ophthalmoplegia + ataxia (B1). Give thiamine before glucose in alcoholics.
- B12 vs folate: both cause megaloblastic anaemia; only B12 causes neurological signs (SACD). Giving folate alone in B12 deficiency corrects anaemia but worsens neuropathy — a favourite trap.
- Methylmalonic acid is raised in B12 deficiency but normal in folate deficiency — the discriminating test.
- Vitamin D activation: 25-hydroxylation in liver, 1-α-hydroxylation in kidney (the regulated step, stimulated by PTH and low phosphate).
- Vitamin A toxicity (pseudotumour cerebri, teratogenicity) and isotretinoin teratogenicity are modern exam points.
Traps
- Pellagra triad = the 3 D's (dermatitis, diarrhoea, dementia); occurs in Hartnup disease and carcinoid syndrome (tryptophan diverted to serotonin) and in isoniazid therapy (B6 depletion).
- INH causes B6 (pyridoxine) deficiency → neuropathy; co-administer pyridoxine.
- Biotin deficiency from raw egg white (avidin binds biotin) — a classic single-line fact.
Group 6: Molecular Biology
High-yield core
This group is technique-dominated and increasingly tested as genetics and molecular diagnostics enter clinical exams.
- Central dogma: DNA → (transcription) → RNA → (translation) → protein. Reverse transcription (RNA → DNA) by retroviruses/telomerase.
- DNA replication: semiconservative; DNA polymerase III (main synthesis in prokaryotes), helicase, primase, ligase, topoisomerase/gyrase. Leading vs lagging strand, Okazaki fragments.
- Mutations: point (silent/missense/nonsense), frameshift (insertion/deletion), trinucleotide repeat expansions (Huntington — CAG; Fragile X — CGG; Friedreich — GAA).
Blotting and detection techniques (the perennial question)
| Technique | Target detected | Mnemonic |
|---|---|---|
| Southern blot | DNA | Southern = DNA |
| Northern blot | RNA | |
| Western blot | Protein | "SNoW DRoP" → DNA-RNA-Protein |
| Southwestern | DNA-binding proteins | |
| ELISA | Antigen/antibody | |
| PCR | Amplify DNA | |
| RT-PCR / qPCR | RNA / quantification | |
| FISH | Chromosomal localisation | |
| CRISPR-Cas9 | Genome editing |
Classic associations
- PCR steps: denaturation (94–95°C) → annealing (~55°C) → extension (72°C, Taq polymerase). Real-time PCR for viral load (HIV, HCV, SARS-CoV-2).
- Sanger sequencing uses chain-terminating dideoxynucleotides (ddNTPs).
- Northern blot for mRNA expression; Western blot confirmatory for HIV (historically) and used in prion disease detection.
Traps
- Western blot = protein, not DNA — the most reversed answer in the subject.
- Confusing transcription factors/promoters/enhancers with operons (lac/trp are prokaryotic).
- Telomerase is a reverse transcriptase — reactivated in most cancers.
Group 7: Metabolism
High-yield core
The capstone group — it ties everything together and is where INI-CET writes its integrated questions. Build a single master sheet of rate-limiting enzymes, pathway locations, and energy yields.
Rate-limiting enzymes (memorise as a block)
| Pathway | Rate-limiting enzyme |
|---|---|
| Glycolysis | Phosphofructokinase-1 (PFK-1) |
| Gluconeogenesis | PEP carboxykinase / fructose-1,6-bisphosphatase |
| Glycogenesis | Glycogen synthase |
| Glycogenolysis | Glycogen phosphorylase |
| TCA cycle | Isocitrate dehydrogenase |
| HMP shunt | Glucose-6-phosphate dehydrogenase (G6PD) |
| Fatty acid synthesis | Acetyl-CoA carboxylase |
| Fatty acid oxidation (entry) | Carnitine palmitoyltransferase-1 (CPT-1) |
| Cholesterol synthesis | HMG-CoA reductase |
| Ketogenesis | HMG-CoA synthase (mitochondrial) |
| Urea cycle | Carbamoyl phosphate synthetase-I (CPS-I) |
| Pyrimidine synthesis | CPS-II |
| Purine synthesis | PRPP amidotransferase (glutamine-PRPP amidotransferase) |
| Haem synthesis | ALA synthase |
Pathway locations
- Cytoplasm only: glycolysis, fatty acid synthesis, HMP shunt, purine/pyrimidine synthesis (partly), glycogen metabolism.
- Mitochondria only: TCA cycle, β-oxidation, oxidative phosphorylation, ketogenesis, part of urea cycle (CPS-I, OTC) and haem synthesis (first + last steps).
- Both: gluconeogenesis, urea cycle, haem synthesis.
Energy yields
- Glucose complete oxidation ≈ 30–32 ATP (modern textbooks); glycolysis nets 2 ATP (anaerobic), TCA + ETC supply the rest.
- NADH ≈ 2.5 ATP, FADH₂ ≈ 1.5 ATP (updated P/O ratios — examiners now accept these).
G6PD deficiency
- X-linked; HMP shunt produces NADPH to keep glutathione reduced. Oxidative stress (fava beans, primaquine, dapsone, sulpha drugs, infection) → Heinz bodies, bite cells, haemolysis. Most common enzymopathy worldwide.
Purine metabolism (TLS, gout, Lesch-Nyhan)
- Final product of purine catabolism = uric acid (via xanthine oxidase).
- Lesch-Nyhan = HGPRT deficiency (X-linked): hyperuricaemia, self-mutilation, choreoathetosis, intellectual disability.
- Adenosine deaminase (ADA) deficiency = SCID.
- Allopurinol/febuxostat inhibit xanthine oxidase; rasburicase for tumour lysis syndrome.
Urea cycle and hyperammonaemia
- OTC deficiency is the most common urea cycle disorder, X-linked, with orotic aciduria without megaloblastic anaemia (vs orotic aciduria type I which has anaemia).
Traps
- HMP shunt makes NADPH and ribose-5-phosphate, NOT ATP.
- Gluconeogenesis cannot use acetyl-CoA / fatty acids as net glucose source (even-chain) — odd-chain FA and glycerol can.
- Brain and RBC are glucose-dependent; RBC has no mitochondria so relies on glycolysis only; in starvation brain adapts to ketones.
Cross-Subject Integration Points
Biochemistry rarely appears in a vacuum in modern papers. Map these overlaps deliberately:
| Biochem topic | Integrates with | Typical question |
|---|---|---|
| Purine/uric acid | Medicine (gout), Pathology (TLS) | Crystal type, allopurinol |
| Lipoproteins | Medicine (CAD), Pharmacology (statins) | ApoB, HMG-CoA reductase |
| Vitamin B12/folate | Pathology (megaloblastic anaemia), Medicine | MMA vs homocysteine |
| Haem synthesis | Pathology (porphyrias), Forensic (lead) | ALA synthase, ALA dehydratase (lead) |
| Collagen | Anatomy, Orthopaedics, Dermatology | Vitamin C, OI, Ehlers-Danlos |
| Glycogen storage | Paediatrics | Von Gierke, Pompe |
| Enzyme kinetics | Pharmacology | Competitive inhibition (statins, fomepizole) |
| Molecular techniques | Microbiology, Pathology | PCR for viral load, FISH |
| Sphingolipidoses | Paediatrics, Ophthalmology | Cherry-red spot |
| HbA1c, ketone bodies | Medicine (diabetes) | Diagnostic cut-offs |
Porphyria-lead link deserves emphasis: lead inhibits ALA dehydratase and ferrochelatase, raising ALA and protoporphyrin — a recurring Forensic/Biochem crossover.
Recent Update Themes and Guideline Shifts
- ATP yield revision: newer editions of standard texts use NADH = 2.5 ATP, FADH₂ = 1.5 ATP, giving ~30–32 ATP per glucose (not the old 36–38). Expect the updated figures.
- Diabetes diagnostic criteria (ADA, carried into Indian practice): fasting plasma glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, random ≥200 mg/dL with symptoms, HbA1c ≥6.5%. Prediabetes HbA1c 5.7–6.4%.
- Newborn screening expansion in India: PKU, congenital hypothyroidism, congenital adrenal hyperplasia, G6PD deficiency and galactosaemia feature in expanding screening panels — vignette fodder.
- Molecular diagnostics surge: PCR/RT-PCR, NGS, CRISPR-Cas9 gene editing, and liquid biopsy concepts now appear in molecular biology questions.
- Lipid guidelines: emphasis on non-HDL cholesterol and ApoB as residual-risk markers, and PCSK9 inhibitors (which increase LDL-receptor recycling) — a fresh pharmacology-biochem crossover.
- Homocysteine as a cardiovascular and thrombosis risk biomarker continues to be examined with its B-vitamin dependencies.
Practical Study Roadmap
Phase 1 — Build the skeleton (first pass, ~2 weeks)
- Make a single master table of rate-limiting enzymes and review it daily.
- Learn the vitamin → active form → deficiency grid until automatic; vitamins alone can carry 2–3 marks.
- Lock down enzyme kinetics graphs (Michaelis-Menten, Lineweaver-Burk, the three inhibition patterns).
Phase 2 — Disease mapping (next 2 weeks)
- Tabulate IEMs as enzyme → accumulated metabolite → clinical clue (especially odours, lens, crystals).
- Memorise GSDs, sphingolipidoses, MPS as comparison tables, not isolated facts.
- Add the blotting/technique table and PCR steps.
Phase 3 — Integration (ongoing)
- Solve previous-year questions (PYQs) — this subject is extremely PYQ-repetitive; the same enzyme-defect and vitamin questions recur across years.
- Practise assertion-reason and "all except" questions for INI-CET.
- Cross-link to Pathology and Medicine as you revise those subjects.
Last-week revision strategy
- Day-wise rapid tables only — do not read theory. Revise: rate-limiting enzymes, vitamins, IEMs, sphingolipidoses, blotting, kinetics, lab cut-offs.
- Re-solve all flagged PYQs and your error log; in Biochemistry, your past mistakes predict your exam mistakes.
- Keep one A4 "numbers sheet": HbA1c cut-offs, ATP yields, Km/Vmax behaviours.
- Sleep on the odour-disease, lens-direction, and cherry-red-spot discriminators — these are the cheapest marks and the most common slips.
High-Yield Mnemonics
- Glycolysis can never let dad buy good pizzas Friday morning — for the enzyme sequence (a popular aid).
- SNoW DRoP — Southern/Northern/Western detect DNA/RNA/Protein.
- "The 3 D's" — pellagra: Dermatitis, Diarrhoea, Dementia (and Death if untreated).
- "WED" — Water-soluble vitamins are Excreted (not stored) except B12; fat-soluble are A, D, E, K.
- "1972" — Vitamin K-dependent clotting factors II, VII, IX, X (plus proteins C and S).
- Fabry, Hunter — the two X-linked lysosomal storage disorders.
- "Down and IN = homocystINuria" — lens dislocation direction.
- "Competitive raises Km, Vmax stays" — kinetics anchor.
Rapid-Fire One-Liners
- Rate-limiting enzyme of cholesterol synthesis → HMG-CoA reductase (statin target).
- Active form of vitamin D → 1,25-dihydroxycholecalciferol (calcitriol); activated in the kidney.
- Most acidic GAG / only intracellular GAG → Heparin.
- Cherry-red spot with hepatosplenomegaly → Niemann-Pick (without HSM → Tay-Sachs).
- Enzyme deficient in classic galactosaemia → galactose-1-phosphate uridyltransferase.
- Discriminator between B12 and folate deficiency → methylmalonic acid (raised only in B12 deficiency).
- Urine darkening on standing → alkaptonuria (homogentisate oxidase deficiency).
- Final product of purine catabolism → uric acid, via xanthine oxidase.
- Lesch-Nyhan syndrome enzyme → HGPRT (X-linked; self-mutilation, hyperuricaemia).
- Competitive inhibition effect → Km increases, Vmax unchanged.
- HMP shunt rate-limiting enzyme / product → G6PD; produces NADPH and ribose-5-phosphate.
- Vitamin C role in collagen → hydroxylation of proline and lysine residues.
This mother page is a navigation hub. Treat each group's table as a revision card, drill the discriminators (odour, lens, cherry-red spot, inhibition kinetics), and rehearse the cross-subject links — that is where NEET PG and INI-CET convert Biochemistry from a "small subject" into reliable marks.
Step-by-step reactions of glycolysis and the citric acid cycle, including key enzymes (hexokinas…
Synthesis and breakdown of glycogen (glycogenin, glycogen phosphorylase, debranching enzyme), gl…
Pentose phosphate pathway reactions producing NADPH and ribose-5-phosphate, G6PD deficiency and …
Hormonal regulation of blood glucose by insulin, glucagon, and cortisol; biochemical basis of ty…
Inborn errors of galactose metabolism (GALT and GALK deficiencies) and fructose metabolism (here…
De novo fatty acid synthesis (acetyl-CoA carboxylase, FAS complex, malonyl-CoA), carnitine shutt…
HMG-CoA reductase pathway, bile acid synthesis, lipoprotein classes (chylomicrons, VLDL, IDL, LD…
Synthesis of ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone) in liver mitochondria, …
Structure and function of phosphatidylcholine, sphingomyelin, cardiolipin, and glycosphingolipid…
Arachidonic acid cascade, COX and LOX pathways, physiological roles of PGs, TXA2, prostacyclin, …
Primary, secondary, tertiary, and quaternary protein structure; forces stabilizing each level; c…
Transamination and deamination, urea cycle steps and enzymes, ammonia toxicity and hyperammonemi…
Folate and B12 in one-carbon transfer, methionine cycle, homocysteine and cardiovascular risk, S…
Hb structure, oxygen-dissociation curve shifts, Bohr and Haldane effects, 2,3-BPG role, HbF vs H…
B1 (thiamine-beriberi), B2 (riboflavin), B3 (niacin-pellagra), B5 (pantothenic acid), B6 (pyrido…
Vitamins A, D, E, and K — absorption, storage, biochemical functions (retinoids in vision, D3 in…
Ascorbic acid as collagen hydroxylation cofactor, antioxidant role, iron absorption enhancement,…
Watson-Crick B-DNA, Chargaff's rules, eukaryotic vs. prokaryotic replication machinery, leading …
RNA polymerases I/II/III and their products, promoter elements, eukaryotic mRNA capping-polyaden…
Genetic code properties (degenerate, non-overlapping, universal exceptions), initiator and termi…
Restriction enzymes, PCR (components, variants), Southern/Northern/Western blotting, DNA sequenc…
Haem biosynthesis steps (ALA synthase to ferrochelatase), rate-limiting enzyme regulation, porph…
De novo and salvage pathways for purines (PRPP, HGPRT) and pyrimidines (carbamoyl phosphate), AD…
Mitochondrial ETC complexes I–IV, chemiosmotic theory, ATP synthase, P/O ratios, uncouplers (DNP…
PTH, calcitonin, and vitamin D in calcium-phosphorus homeostasis; iron absorption (DMT1, ferropo…
Organ-specific metabolism (liver, muscle, brain, adipose, RBC), metabolic priorities in fed, fas…